Bibliometric Analysis of PD-1/PD-L1 Inhibitor Resistance Research, 2006-2025

2,122 studies on resistance to PD-1/PD-L1 inhibitors published between 2006 and 2025 were analyzed. The dataset was compiled by Lehan Miao from the Web of Science Core Collection and Scopus databases using bibliometric tools. It highlights leading countries, institutions, journals, and emerging research hotspots in the field.

Use Cases

• Analyze publication trends and growth in PD-1/PD-L1 resistance research based on the described timeline from 2006 to 2025.
• Map international collaboration networks among researchers and institutions based on the described country-level contributions.
• Identify emerging research hotspots and keywords like 'tumor microenvironment' and 'combination strategy' based on the analysis results mentioned.
• Assess the influence of specific journals and authors, such as the Journal of Clinical Oncology and Stephen L. Topalian, based on the bibliometric findings.

Strengths

• Contains metadata for 2,122 research documents, providing a substantial sample for analysis.
• Covers a 20-year time range from 2006 to 2025, allowing for longitudinal trend analysis.
• Includes geographic and institutional authorship data, with China and the United States identified as leading contributors.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic or source bias inherent to the Web of Science and Scopus databases.

Provenance

Source

Web of Science Core Collection and Scopus databases.

Collection Method

Systematic retrieval and analysis using bibliometric tools, followed by secondary screening and classification.

Time Range

2006-01-01 to 2025-11-29

Freshness

Last updated 2026-05-28 06:20:18; freshness should be verified.

Geography

Global, with specific mention of China and the United States.